Systemic treatment with interferon-alpha 2B: an effective method to prevent sterility after bilateral mumps orchitis
- PMID: 2056606
- DOI: 10.1016/s0022-5347(17)37713-3
Systemic treatment with interferon-alpha 2B: an effective method to prevent sterility after bilateral mumps orchitis
Abstract
In men orchitis represents the most common complication of mumps infection and occurs in 5 to 37% of this population. Bilateral manifestation is observed in 16 to 65% of the patients. The most important danger is the risk of testicular atrophy which results in sterility. Four patients with bilateral mumps orchitis received systemic treatment with interferon-alpha 2B (3 x 10(6) IU per day) for 7 days. All acute symptoms of mumps orchitis disappeared within 2 to 4 days of hospitalization. During 6 to 15 months of followup no incidence of testicular atrophy was observed. In 3 of 4 patients pre-treatment examination revealed subfertility (oligoasthenospermia), while 2 to 4 months after interferon treatment, as well as during the entire followup period normospermia was found. No severe adverse effects occurred during treatment. The flu-like symptoms could be prevented by concomitant administration of paracetamol (500 mg. 3 times a day). Systemic treatment with interferon-alpha 2B appears to be highly effective in preventing sterility and testicular atrophy after bilateral mumps orchitis. Further investigations involving larger populations should be performed to establish the present promising results.
Similar articles
-
Mumps Orchitis: Clinical Aspects and Mechanisms.Front Immunol. 2021 Mar 18;12:582946. doi: 10.3389/fimmu.2021.582946. eCollection 2021. Front Immunol. 2021. PMID: 33815357 Free PMC article. Review.
-
[Systemic alpha-interferon therapy: a possible method for prevention of testicular atrophy and permanent sterility in patients with bilateral mumps orchitis].Urologe A. 1991 Jul;30(4):244-8. Urologe A. 1991. PMID: 1926670 German.
-
Role of interferon-alpha-2B in prevention of testicular atrophy with unilateral mumps orchitis.Urology. 2000 Jun;55(6):931-3. doi: 10.1016/s0090-4295(00)00491-x. Urology. 2000. PMID: 10840112
-
Successful interferon-alpha 2 a therapy for a patient with acute mumps orchitis.Eur Urol. 1995;27(2):174-6. doi: 10.1159/000475153. Eur Urol. 1995. PMID: 7744163
-
The increasing incidence of mumps orchitis: a comprehensive review.BJU Int. 2010 Apr;105(8):1060-5. doi: 10.1111/j.1464-410X.2009.09148.x. Epub 2010 Jan 11. BJU Int. 2010. PMID: 20070300 Review.
Cited by
-
Atypical Mumps; are We Heading Towards an Outbreak?Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4138-4145. doi: 10.1007/s12070-024-04802-9. Epub 2024 Jun 20. Indian J Otolaryngol Head Neck Surg. 2024. PMID: 39376365
-
Viral Infections and Male Infertility: A Comprehensive Review of the Role of Oxidative Stress.Front Reprod Health. 2022 Feb 3;4:782915. doi: 10.3389/frph.2022.782915. eCollection 2022. Front Reprod Health. 2022. PMID: 36303638 Free PMC article. Review.
-
The Role of Stem Cells and Their Derived Extracellular Vesicles in Restoring Female and Male Fertility.Cells. 2021 Sep 17;10(9):2460. doi: 10.3390/cells10092460. Cells. 2021. PMID: 34572109 Free PMC article. Review.
-
Mumps Orchitis: Clinical Aspects and Mechanisms.Front Immunol. 2021 Mar 18;12:582946. doi: 10.3389/fimmu.2021.582946. eCollection 2021. Front Immunol. 2021. PMID: 33815357 Free PMC article. Review.
-
Viral infections and implications for male reproductive health.Asian J Androl. 2021 Jul-Aug;23(4):335-347. doi: 10.4103/aja.aja_82_20. Asian J Androl. 2021. PMID: 33473014 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical